Allows certain medications in multidose containers used by a patient during a hospital stay to be sent with the patient at discharge
HB187 would add a new section to Missouri law allowing certain medications that were used during a patient’s hospital stay and stored in multidose containers to be sent home with the patient at discharge, or transferred to another healthcare facility, if ordered by an authorized healthcare provider. The bill specifically identifies examples such as inhalers, ointments, creams, insulin pens and vials, eyedrops, eardrops, wearable or on-body medication delivery systems, and infusions currently connected to a patient’s infusion device.
The bill also sets labeling requirements for these medications, including the date, patient name, prescriber name, hospital name and address, medication name and strength, and instructions for use. Labeling could be done by a pharmacist, prescriber, or registered nurse, and the discharge instructions could reference separate written instructions provided at discharge. Controlled substances generally could not be sent with the patient, except for certain wearable or on-body delivery systems or connected infusions when needed for transport, documented in the medical record, and reported to the pharmacy. The bill further states that it would not require a class B hospital pharmacy to obtain additional licensure or comply with additional regulatory requirements.
HB187 would create a new statutory authorization in chapter 197, RSMo, governing discharge of multidose medications from hospitals. It would affect hospitals, hospital pharmacies, pharmacists, prescribers, registered nurses, and patients by establishing when and how certain medications may accompany a patient at discharge, while also carving out limits for controlled substances and preserving existing licensure rules for class B hospital pharmacies.
Based on the bill text and the absence of recorded committee testimony or votes in the provided materials, the measure appears to be a practical, patient-centered healthcare bill with no documented opposition in the record provided. Its purpose suggests a generally favorable policy approach aimed at improving continuity of care and reducing medication disruption at discharge.
The main potential points of contention are the handling of controlled substances and the operational responsibilities placed on hospitals and staff. The bill allows only narrow exceptions for controlled-substance delivery systems or connected infusions, and it requires documentation and pharmacy notification, which may raise compliance concerns. Another possible issue is whether hospitals and discharge staff can consistently meet the labeling and documentation requirements without adding administrative burden, although the bill explicitly says it does not impose additional licensure requirements on class B hospital pharmacies.